Angeliq 2+1 mg filmovertrukne tabletter ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

angeliq 2+1 mg filmovertrukne tabletter

paranova danmark a/s - drospirenon, estradiolhemihydrat - filmovertrukne tabletter - 2+1 mg

Paravelle 0,5+1 mg tabletter ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

paravelle 0,5+1 mg tabletter

paranova danmark a/s - estradiolvalerat, norethisteronacetat - tabletter - 0,5+1 mg

Ariclaim ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

ariclaim

eli lilly nederland b.v. - duloxetin - diabetiske neuropatier - psychoanaleptics, - behandling af diabetisk perifer neuropatisk smerte. ariclaim er indiceret hos voksne.

Duloxetine Boehringer Ingelheim ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

duloxetine boehringer ingelheim

boehringer ingelheim international gmbh - duloxetin - diabetiske neuropatier - psychoanaleptics, - behandling af diabetisk perifer neuropatisk smerte hos voksne.

Mekinist ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

mekinist

novartis europharm limited - trametinib - melanom - antineoplastiske midler - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 og 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. ikke-småcellet lungekræft (nsclc)trametinib i kombination med dabrafenib er indiceret til behandling af voksne patienter med avanceret ikke-småcellet lungekræft med en braf v600 mutation.